Filter Results:
(89)
Show Results For
- All HBS Web
(163)
- News (45)
- Research (89)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
Show Results For
- All HBS Web
(163)
- News (45)
- Research (89)
- Events (1)
- Multimedia (5)
- Faculty Publications (54)
Sort by
- October 2000
- Supplement
Hans Fritz at Novartis Thailand (C)
By: Carin-Isabel Knoop and Michael Y. Yoshino
Supplements the (A) case. View Details
Knoop, Carin-Isabel, and Michael Y. Yoshino. "Hans Fritz at Novartis Thailand (C)." Harvard Business School Supplement 301-054, October 2000.
- October 1998
- Teaching Note
Jan Eriksson at Novartis Indonesia TN
By: Carin-Isabel Knoop and Anthony St. George
Teaching Note for (9-898-219), (9-899-040), and (9-898-220). View Details
- December 1999 (Revised September 2000)
- Case
Novartis Agricultural Discovery Institute, Inc. (B)
Supplements the (A) case. View Details
West, Jonathan, and Christian G. Kasper. "Novartis Agricultural Discovery Institute, Inc. (B)." Harvard Business School Case 600-042, December 1999. (Revised September 2000.)
- August 1998 (Revised October 1998)
- Case
Jan Eriksson at Novartis Indonesia (B)
By: Carin-Isabel Knoop and Anthony St. George
Supplements the (A) case. View Details
Knoop, Carin-Isabel, and Anthony St. George. "Jan Eriksson at Novartis Indonesia (B)." Harvard Business School Case 899-033, August 1998. (Revised October 1998.)
- July 2008 (Revised May 2017)
- Teaching Note
Financial Leadership in Novartis Consumer Health Businesses
By: Boris Groysberg and Geoff Marietta
Teaching Note for HBS No. 406-102. View Details
- November 2011 (Revised February 2012)
- Case
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details
Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Health Industry; China
Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Case 612-048, November 2011. (Revised February 2012.)
- June 2012
- Teaching Note
Cynthia Hogan and the Birth of Novartis (TN)
By: Rosabeth M. Kanter and Matthew Bird
- July 1998 (Revised October 1998)
- Case
Jan Eriksson at Novartis Indonesia: Turmoil in the Indonesian Pharmaceutical Industry
By: Carin-Isabel Knoop and Anthony St. George
Jan Eriksson is the country manager of the Indonesian joint venture of Basel-based Novartis (Novartis Indonesia), the world's largest pharmaceutical company, formed by the 1996 merger between Sandoz and Ciba-Geigy. The case describes the actions he has taken since... View Details
Keywords: Joint Ventures; Mergers and Acquisitions; Crisis Management; Management Teams; Financial Crisis; Pharmaceutical Industry; Indonesia
Knoop, Carin-Isabel, and Anthony St. George. "Jan Eriksson at Novartis Indonesia: Turmoil in the Indonesian Pharmaceutical Industry." Harvard Business School Case 899-040, July 1998. (Revised October 1998.)
- December 1996 (Revised June 2003)
- Case
Cynthia Hogan and the Birth of Novartis
An American woman heads an integration office for merger transition activities between two giant Swiss pharmaceutical companies. She needed to develop an implementation plan to shape the new global powerhouse. View Details
- October 2000
- Supplement
Hans Fritz at Novartis Thailand (D): The First 18 Months
By: Michael Y. Yoshino and Carin-Isabel Knoop
Supplements the (A) case. View Details
Yoshino, Michael Y., and Carin-Isabel Knoop. "Hans Fritz at Novartis Thailand (D): The First 18 Months." Harvard Business School Supplement 301-055, October 2000.
- March 1999 (Revised January 2001)
- Case
Hans Fritz at Novartis Thailand (B): The First Six Months
By: Michael Y. Yoshino and Carin-Isabel Knoop
Supplements the (A) case. View Details
Yoshino, Michael Y., and Carin-Isabel Knoop. "Hans Fritz at Novartis Thailand (B): The First Six Months." Harvard Business School Case 399-124, March 1999. (Revised January 2001.)
- May 2013
- Teaching Plan
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato and Annelena Lobb
Sato, Vicki, and Annelena Lobb. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Teaching Plan 613-103, May 2013.
- December 2014 (Revised October 2017)
- Case
Social Business at Novartis: Arogya Parivar
By: Michael E. Porter, Mark R. Kramer and David Lane
Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of... View Details
Keywords: Shared Value; India; Kenya; Vietnam; Novartis; Arogya Parivar; Social Business; Multinational Firms and Management; Competitive Advantage; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Viet Nam; Kenya; India
Porter, Michael E., Mark R. Kramer, and David Lane. "Social Business at Novartis: Arogya Parivar." Harvard Business School Case 715-411, December 2014. (Revised October 2017.)
- January 2017 (Revised October 2018)
- Case
Novartis: A Transformative Deal
By: David Collis and Ashley Hartman
When Joe Jimenez became CEO of Swiss-based Novartis in 2010, replacing longtime CEO Dan Vasella, he assumed control of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and... View Details
Keywords: Novartis; GlaxoSmithKline; Asset Swap; Acquisitions; Divestiture; Strategy Alignment; Pharmaceuticals; Strategy; Business Strategy; Corporate Strategy; Diversification; Consolidation; Mergers and Acquisitions; Pharmaceutical Industry
Collis, David, and Ashley Hartman. "Novartis: A Transformative Deal." Harvard Business School Case 717-453, January 2017. (Revised October 2018.)
- June 1998
- Supplement
MBA Integrative Exercise: Competition & Strategy, April 1998 , Video
By: Carin-Isabel Knoop
Daniel Vasella, President of Novartis AG, discusses the situation in Indonesia and his ideas of what Suharto should do in the spring of 1998. Drummond Paris, Regional Pharma Head Asia/Pacific, Novartis AG, discusses the opportunities for Novartis in Indonesia and also... View Details
Knoop, Carin-Isabel. "MBA Integrative Exercise: Competition & Strategy, April 1998 , Video." Harvard Business School Video Supplement 898-504, June 1998.
- May 2000
- Case
To Trim or Not to Trim: That Is the Question
By: Srikant M. Datar
Should Novartis drop 20% of its global pharmaceutical product brands that account for only 3% of its pharmaceutical revenues? View Details
Keywords: Business Earnings; Cost vs Benefits; Business Strategy; Investment Return; Problems and Challenges; Pharmaceutical Industry
Datar, Srikant M. "To Trim or Not to Trim: That Is the Question." Harvard Business School Case 100-105, May 2000.
- April 2003 (Revised October 2004)
- Case
Novartis: The Challenge of Success (B)
By: Sandra J. Sucher and Stacy McManus
When Dr. Daniel Vasella learned of the early Phase 1 trial results, he immediately decided what course of action Novartis would take. Students will be able to examine and assess the concrete steps, and the rationale behind them, that Novartis took in response to this... View Details
Keywords: Decision Making; Moral Sensibility; Innovation and Invention; Distribution; Product Development; Production; Problems and Challenges; Research and Development; Biotechnology Industry; Pharmaceutical Industry
Sucher, Sandra J., and Stacy McManus. "Novartis: The Challenge of Success (B)." Harvard Business School Case 603-044, April 2003. (Revised October 2004.)
- June 1998
- Supplement
MBA Integrative Exercise: General Management, April 1998
By: Carin-Isabel Knoop
Drummond Paris, Regional Pharma Head, Asia/Pacific Novartis AG, discusses the company situation in Indonesia: joint ventures, budget, keeping track, and the prognosis for the future. View Details
Keywords: Business or Company Management; Joint Ventures; Forecasting and Prediction; Pharmaceutical Industry; Indonesia
Knoop, Carin-Isabel. "MBA Integrative Exercise: General Management, April 1998." Harvard Business School Video Supplement 898-503, June 1998.
- 2011
- Interview
Creating Shared Value: Connecting Business, Societal Value and Opportunity
By: Michael E. Porter, Mark R. Kramer and Jane Nelson
Michael Porter, Mark Kramer and Jane Nelson discuss creating shared value and give examples from HP, Nestlé and Novartis on how corporations can put this approach into practice. For more more information on creating shared value, visit www.fsg.org View Details
Keywords: Creating Shared Value; Value Creation; Corporate Social Responsibility and Impact; Business and Community Relations
Porter, Michael E., Mark R. Kramer, and Jane Nelson. "Creating Shared Value: Connecting Business, Societal Value and Opportunity." FSG, 2011.
- May 2013 (Revised October 2014)
- Case
Novartis: Leading a Global Enterprise
By: William W. George, Krishna G. Palepu and Carin-Isabel Knoop
Novartis, the world's leading healthcare company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case traces the company's evolution over the past 17 years, as it transformed into a truly global enterprise... View Details
Keywords: Multinational Firms and Management; Talent and Talent Management; Organizational Structure; Organizational Culture; Success; Globalized Markets and Industries; Management Teams; Change Management; Business History; Mergers and Acquisitions; Global Strategy; Health Care and Treatment; Pharmaceutical Industry; Health Industry; Switzerland
George, William W., Krishna G. Palepu, and Carin-Isabel Knoop. "Novartis: Leading a Global Enterprise." Harvard Business School Case 413-096, May 2013. (Revised October 2014.)